Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 16 years of age and older. The booster dose is to be administered at least six months […]
Pfizer: Pfizer And BioNTech Receive U.S. FDA Emergency Use Authorization Of COVID-19 Vaccine Booster For Individuals 16 Years And Older
- Post author:admin
- Post published:December 13, 2021
- Post category:Uncategorized
Tags: Education News